CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
↓ Download CSV- Sector Services
- Fiscal year ends Dec 27
In fiscal 2025, CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported revenue of $4.02B, down 0.9% from the prior year. The company ran a net loss, with a net margin of -3.5%. It held $7.14B in total assets against $3.92B in total liabilities.
Key ratios (FY2025)
0.6%
Operating margin
-3.5%
Net margin
-4.5%
Return on equity
-0.9%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B |
| Cost of Revenue | — | — | — | — | — | — | — | — | $289.67M | $277.03M |
| Operating Income | $25.16M | $227.35M | $617.26M | $650.98M | $589.86M | $432.73M | $351.15M | $331.38M | $288.28M | $237.55M |
| Net Income | -$142.16M | $25.29M | $480.37M | $492.61M | $398.84M | $365.31M | $254.06M | $228.72M | $125.45M | $156.37M |
| EPS (Diluted) | $-2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 |
| Total Assets | $7.14B | $7.53B | $8.20B | $7.60B | $7.02B | $5.49B | $4.69B | $3.86B | $2.93B | $2.71B |
| Total Liabilities | $3.92B | $4.02B | $4.54B | $4.58B | $4.43B | $3.35B | $3.03B | $2.52B | $1.87B | $1.86B |
| Shareholders' Equity | $3.17B | $3.47B | $3.60B | $2.98B | $2.54B | $2.12B | $1.64B | $1.32B | $1.05B | $839.12M |
| Cash & Equivalents | $213.77M | $194.61M | $276.77M | $233.91M | $241.21M | $228.42M | $238.01M | $195.44M | $163.79M | $117.63M |
| Operating Cash Flow | $737.65M | $734.58M | $683.90M | $619.64M | $760.80M | $546.58M | $480.94M | $441.14M | $318.07M | $316.90M |
| Capital Expenditures | $219.15M | $232.97M | $318.53M | $324.73M | $228.77M | $166.56M | $140.51M | $140.05M | $82.43M | $55.29M |
| Shares Outstanding | 49.56M | 51.63M | 51.45M | 51.30M | 51.42M | 50.61M | 49.69M | 49.02M | 48.56M | 47.96M |